FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912863307> ?p ?o ?g. }

• W2912863307 endingPage "3620" @default.
• W2912863307 startingPage "3620" @default.
• W2912863307 abstract "Abstract Diamond Blackfan Anemia (DBA) is an inherited bone marrow failure syndrome that is frequently managed with glucocorticoids to increase red cell mass. Despite sustained effective clinical use for many decades in DBA and other anemias, we still do not fully understand the mechanistic basis for the regulation of human erythropoiesis by glucocorticoids. In order to improve the clinical management of patients with DBA, we studied the mechanisms of action of dexamethasone (Dex) on erythroid progenitors. To study the effects of Dex on erythroid progenitor biology, we employed a serum-free erythroid culture system to differentiate primary human CD34+ cells isolated from the peripheral blood of adults or DBA patients as well as cord blood samples. We found that Dex increases the total proliferation of CD34+ cells from adult peripheral blood but not in cord blood over 14 days in culture. Dex treatment also led to an acceleration of the BFU-E to CFU-E transition in peripheral blood with a minimal effect in cord blood. In methylcellulose colony forming assays, peripheral blood derived CFU-E treated with Dex for 24hrs produced more colonies or larger colonies than the untreated controls while a lesser effect was seen in cord blood derived CFU-E. Both assays revealed that Dex treatment enhanced self-renewal of peripheral blood derived CFU-E. We also noted that BFU-E and CFU-E differentially express the glucocorticoid receptor (GR) isoforms, GRα and GRβ. BFU-E expressed comparable levels of GRα and the dominant-negative GRβ, whereas only the GRα transcript was identified in CFU-E. We observed similar expression patterns for GR between peripheral and cord blood derived progenitors. Importantly, following Dex treatment, GRα was shown to translocate to the nucleus of erythroid progenitors derived from peripheral blood derived CD34+ cells but not in the cord blood derived progenitors. When we examined the cell cycle progression of sorted human erythroid progenitors, CFU-E and BFU-E, we observed a G0/G1 arrest of peripheral blood CFU-E treated with Dex compared to untreated CFU-E. In marked contrast, no such change was noted for either Dex treated BFU-E from peripheral blood or for CFU-E or BFU-E from cord blood. In addition, we found an increase in the expression of cell cycle regulators p57Kip2 and p27Kip1 in Dex treated peripheral blood CFU-E but no such increased expression was seen in cord blood CFU-E. When peripheral blood derived erythroid progenitors were treated with olomoucine (Olo), a small molecule CDK inhibitor, we observed an acceleration of the BFU-E to CFU-E transition similar to that induced by Dex. Upon co-treatment with Dex and Olo, there was a synergistic effect in the accelerated formation of CFU-E population from BFU-Es. To validate this finding of the dependence of CFU-E on cell cycle regulators, we transduced peripheral blood derived CD34+ cells with a lentiviral shRNA construct to knockdown p57 expression. Following successful knockdown of the expression levels of p57, the numbers of CFU-E indeed decreased implying a role for cell cycle in defective transition of BFU-E to CFU-E. Erythroid progenitors derived from cultures of primary CD34+ cells from DBA patients were also studied. Importantly, we noted increased baseline expression of p57Kip2 and p27Kip1 in erythroid progenitors from steroid resistant DBA patients and in contrast to controls, their expression did not increase following Dex treatment. Our findings provide novel mechanistic insights into the regulation of human erythropoiesis by Dex. We have shown that alterations in cell cycle regulation of erythroid progenitors plays a key role in the effects of glucocorticoids on red blood cells. Furthermore, this work has direct relevance for the development of improved therapeutic treatment strategies for patients with bone marrow failure syndromes such as DBA. Disclosures No relevant conflicts of interest to declare." @default.
• W2912863307 created "2019-02-21" @default.
• W2912863307 creator A5000821531 @default.
• W2912863307 creator A5007853865 @default.
• W2912863307 creator A5010465278 @default.
• W2912863307 creator A5031159776 @default.
• W2912863307 creator A5034746599 @default.
• W2912863307 creator A5034912242 @default.
• W2912863307 creator A5044759942 @default.
• W2912863307 creator A5049012918 @default.
• W2912863307 creator A5071154052 @default.
• W2912863307 date "2018-11-29" @default.
• W2912863307 modified "2023-09-30" @default.
• W2912863307 title "Dexamethasone Accelerates the Transition of Human BFU-E to CFU-E and Enhances CFU-E Proliferation through Cell Cycle Regulation" @default.
• W2912863307 doi "https://doi.org/10.1182/blood-2018-99-116596" @default.
• W2912863307 hasPublicationYear "2018" @default.
• W2912863307 type Work @default.
• W2912863307 sameAs 2912863307 @default.
• W2912863307 citedByCount "0" @default.
• W2912863307 crossrefType "journal-article" @default.
• W2912863307 hasAuthorship W2912863307A5000821531 @default.
• W2912863307 hasAuthorship W2912863307A5007853865 @default.
• W2912863307 hasAuthorship W2912863307A5010465278 @default.
• W2912863307 hasAuthorship W2912863307A5031159776 @default.
• W2912863307 hasAuthorship W2912863307A5034746599 @default.
• W2912863307 hasAuthorship W2912863307A5034912242 @default.
• W2912863307 hasAuthorship W2912863307A5044759942 @default.
• W2912863307 hasAuthorship W2912863307A5049012918 @default.
• W2912863307 hasAuthorship W2912863307A5071154052 @default.
• W2912863307 hasBestOaLocation W29128633071 @default.
• W2912863307 hasConcept C10205521 @default.
• W2912863307 hasConcept C109159458 @default.
• W2912863307 hasConcept C126322002 @default.
• W2912863307 hasConcept C134018914 @default.
• W2912863307 hasConcept C201750760 @default.
• W2912863307 hasConcept C203014093 @default.
• W2912863307 hasConcept C2777279920 @default.
• W2912863307 hasConcept C2778248108 @default.
• W2912863307 hasConcept C2779703530 @default.
• W2912863307 hasConcept C2780007613 @default.
• W2912863307 hasConcept C2780401358 @default.
• W2912863307 hasConcept C2780841215 @default.
• W2912863307 hasConcept C2780914630 @default.
• W2912863307 hasConcept C28328180 @default.
• W2912863307 hasConcept C71924100 @default.
• W2912863307 hasConcept C86803240 @default.
• W2912863307 hasConcept C95444343 @default.
• W2912863307 hasConceptScore W2912863307C10205521 @default.
• W2912863307 hasConceptScore W2912863307C109159458 @default.
• W2912863307 hasConceptScore W2912863307C126322002 @default.
• W2912863307 hasConceptScore W2912863307C134018914 @default.
• W2912863307 hasConceptScore W2912863307C201750760 @default.
• W2912863307 hasConceptScore W2912863307C203014093 @default.
• W2912863307 hasConceptScore W2912863307C2777279920 @default.
• W2912863307 hasConceptScore W2912863307C2778248108 @default.
• W2912863307 hasConceptScore W2912863307C2779703530 @default.
• W2912863307 hasConceptScore W2912863307C2780007613 @default.
• W2912863307 hasConceptScore W2912863307C2780401358 @default.
• W2912863307 hasConceptScore W2912863307C2780841215 @default.
• W2912863307 hasConceptScore W2912863307C2780914630 @default.
• W2912863307 hasConceptScore W2912863307C28328180 @default.
• W2912863307 hasConceptScore W2912863307C71924100 @default.
• W2912863307 hasConceptScore W2912863307C86803240 @default.
• W2912863307 hasConceptScore W2912863307C95444343 @default.
• W2912863307 hasIssue "Supplement 1" @default.
• W2912863307 hasLocation W29128633071 @default.
• W2912863307 hasOpenAccess W2912863307 @default.
• W2912863307 hasPrimaryLocation W29128633071 @default.
• W2912863307 hasRelatedWork W1812483684 @default.
• W2912863307 hasRelatedWork W1998228373 @default.
• W2912863307 hasRelatedWork W2044559595 @default.
• W2912863307 hasRelatedWork W2054167115 @default.
• W2912863307 hasRelatedWork W2097466377 @default.
• W2912863307 hasRelatedWork W2416649916 @default.
• W2912863307 hasRelatedWork W2516866347 @default.
• W2912863307 hasRelatedWork W2518614969 @default.
• W2912863307 hasRelatedWork W2734587145 @default.
• W2912863307 hasRelatedWork W1968377433 @default.
• W2912863307 hasVolume "132" @default.
• W2912863307 isParatext "false" @default.
• W2912863307 isRetracted "false" @default.
• W2912863307 magId "2912863307" @default.
• W2912863307 workType "article" @default.